Cargando…
Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes
AIMS: Aim of the present study was to evaluate the impact of once-weekly semaglutide on different end-points indicative of metabolic control, cardiovascular risk, dietary behavior, and treatment satisfaction in T2DM. METHODS: This was a retrospective observational study conducted in a diabetes clini...
Autores principales: | Di Folco, Ugo, Vallecorsa, Noemi, Nardone, Maria Rosaria, Pantano, Angelo Lauria, Tubili, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288662/ https://www.ncbi.nlm.nih.gov/pubmed/35842847 http://dx.doi.org/10.1007/s00592-022-01936-6 |
Ejemplares similares
-
Semaglutide for type 2 diabetes
Publicado: (2020) -
Emotional eating and disordered eating behaviors in children and adolescents with type 1 diabetes
por: Ripoli, Carlo, et al.
Publicado: (2022) -
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
por: Husain, Mansoor, et al.
Publicado: (2020) -
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2023) -
A Significant Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
por: Yanai, Hidekatsu, et al.
Publicado: (2022)